Literature DB >> 12126492

Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.

Colin Brewer1.   

Abstract

The maximum dose of heroin that is blocked by customary doses of oral naltrexone (NTX) and its active metabolite 6-beta-naltrexol (6BNT) is unknown, particularly at trough serum levels which show much interindividual variation and can be low. NTX has only once been tested formally against opiate equivalents of more than 25 mg of diamorphine. Increasing interest in long-acting implantable NTX preparations makes it important to have objective information about blocking activity at various blood levels of NTX and 6BNT. Two cases are described in which NTX and 6BNT levels as low as 2.8 and 9.0 ng/ml, respectively, were sufficient to block doses of pure diamorphine as high as 500 mg.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126492     DOI: 10.1080/13556210220139541

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  5 in total

1.  Plasma concentrations during naltrexone implant treatment of opiate-dependent patients.

Authors:  Linda Olsen; Asbjørg S Christophersen; Grete Frogopsahl; Helge Waal; Jørg Mørland
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

2.  Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.

Authors:  Gary K Hulse; Robert J Tait; Sandra D Comer; Maria A Sullivan; Ian G Jacobs; Diane Arnold-Reed
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

3.  Long-acting injectable naltrexone for the management of patients with opioid dependence.

Authors:  Kimberly L Kjome; F Gerard Moeller
Journal:  Subst Abuse       Date:  2011-02-06

4.  Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.

Authors:  Laurel S Morris; Kwangyeol Baek; Roger Tait; Rebecca Elliott; Karen D Ersche; Remy Flechais; John McGonigle; Anna Murphy; Liam J Nestor; Csaba Orban; Filippo Passetti; Louise M Paterson; Ilan Rabiner; Laurence Reed; Dana Smith; John Suckling; Eleanor M Taylor; Edward T Bullmore; Anne R Lingford-Hughes; Bill Deakin; David J Nutt; Barbara J Sahakian; Trevor W Robbins; Valerie Voon
Journal:  Addict Biol       Date:  2017-02-28       Impact factor: 4.280

5.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.